Search

everythinglearnresearchcommunity

for

Search:↓

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Pyruvate Kinase M2 helps hair grow by linking energy production and a key hair growth pathway.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Duloxetine, escitalopram, and finasteride may be effective against bacteria and fungi.

Potassium channel openers help form elastic fibers in arteries and can treat elastin deficiency and hypertension.

JAK inhibitors are effective treatments for alopecia areata.

Antizyme slows skin tumor growth by reducing cell growth in mice.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.

The developed scaffold effectively treats chronic wounds by promoting healing and preventing infection.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Sgk3 kinase is essential for normal hair growth in mice.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.